PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ETHYLENEDIAMINES”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 19 recordsLinked to original sources

Bicarbonate-dependence of responses to ethylenediamine in the guinea-pig isolated ileum: involvement of ethylenediamine-monocarbamate.

gamma-Aminobutyric-acid (GABA)-mimetic responses were induced by ethylenediamine (EDA) in the isolated ileum of the guinea-pig maintained in bicarbonate buffered Krebs-Henseleit (KBC) solution, pH 7.4, 37 degrees C, the responses consisting of a contraction followed by a relaxation. There were no such responses to EDA in bicarbonate-free phosphate buffered (KPO) or HEPES buffered (KHO) Krebs solution, gassed with 100% O2, pH 7.4, 37 degrees C, yet the ileum responded to GABA in bicarbonate-free Krebs solution. Similar GABA-mimetic responses were induced by EDA in the isolated ileum maintained in bicarbonate-free KPO or KHO modified Krebs solution, gassed with O2, if HCO3- (5mM) was first added immediately before the test dose of EDA (0.1-1 mM), the threshold [HCO3-]being 2 mM for EDA-induced responses in these preparations. However, ileal GABA-mimetic responses were induced in bicarbonate-free KPO or KHO solutions by EDA that had been pretreated with carbon dioxide, where the final [HCO3-]in the bath did not exceed 25 microM. Ethylenediamine monocarbamate (synthetic EDAC) released [3H]-GABA from preloaded segments of ileum maintained in bicarbonate-free KPO or KHO solution containing amino-oxyacetic acid and beta-alanine, the release being sensitive to 3-mercaptopropionic acid which prevents GABA release. EDA itself did not evoke any such release in the absence of bicarbonate, but released [3H]-GABA from segments maintained in KBC solution. 4 GABA-mimetic responses were induced by EDAC in the isolated ileum maintained in bicarbonate-free KPO solution, as was a delta-aminovalerate-sensitive depression of ileal twitch responses elicited by transmural stimulation, all of which were also sensitive to 3-mercaptopropionic acid. 5 It is concluded that GABA-mimetic responses to EDA in the isolated ileum of the guinea-pig, maintained in normal Krebs bicarbonate medium, result from the release of endogenous GABA by ethylenediamine monocarbamate formed through the rapid reaction of EDA with the carbon dioxide of bicarbonate buffered Krebs solution. Furthermore, in the ileum, HCO3 ions per se are not necessary for this GABA-releasing property of EDA if the latter is first converted to the monocarbamate, since syntheticethylenediamine monocarbamate elicits ileal GABA-mimetic responses in the total absence of bicarbonate.

Animals↗

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part II. Studies on the influence of [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine] dichloroplatinum(II) on the specific immune defense in MXT-M-3,2 breast cancer bearing mice.

The anti-tumor activity of [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) on the MXT-M-3,2 breast cancer implanted into B6D2F1 mice was not significantly reduced by splenectomy or co-administration of cyclosporine A. Neither did the use of T-lymphocyte-deficient NMRI (nu/nu) mice as hosts substantially influence its anti-tumor effect. Obviously, [meso-1,2-bis(2,6-dichloro-4- hydroxyphenyl)ethylenediamine]dichloroplatinum(II) does not act by an enhancement of the specific immune defense.

Animals↗

Synthesis and antitumour activity of platinum(II) and platinum(IV) complexes containing ethylenediamine-derived ligands having alcohol, carboxylic acid and acetate substituents. Crystal and molecular structure of [PtL4CL2].H20 where L4 is ethylenediamine-N,N'-diacetate.

Several cisplatin analogues of ethylenediamine-derived ligands containing alcohol, carboxylic acid and acetate substituents have been prepared and characterised. Oxidation of some of these square planar platinum(II) complexes using aqueous hydrogen peroxide gave octahedral platinum(IV) complexes, containing trans hydroxo ligands. Acetylation of the hydroxo ligands was achieved by reaction with acetic anhydride, giving complexes which are analogues of the antitumour drug, JM-216. Oxidation of the complex [Pt(H2L4)Cl2], where H2L4 is ethylenediamine-N,N'-diacetic acid, with H2O2 gave the platinum(IV) complex [PtL4Cl2].H2O in which L4 is tetradentate as shown by a crystal and molecular structure. This complex was previously reported to be [Pt(HL4)(OH)Cl2] in which HL4 is tridentate. Several of the complexes were tested for antitumour activity against five human ovarian carcinoma cell lines. IC50 values range from 4.0 microM for cis,trans-PtCl2(OH)2(NH2CH2CH2NHCH2CH2OH) against the CH1 cell line to >25 microM indicating moderate to low activity relative to other platinum complexes.

Antineoplastic Agents↗

Investigation of the configurational and conformational influences on the hormonal activity of 1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamines and of their platinum(II) complexes. 1. Synthesis, estradiol receptor affinity, and estrogenic activity of diastereomeric [N-alkyl- and N,N'-dialkyl-1,2- bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) complexes.

N-Monoalkylated (Et) and N,N'-dialkylated (Me and Et) 1,2-bis(2,6-dichloro-4-hydroxyphenyl)-ethylenediamines and their dichloroplatinum(II) complexes were synthesized, and their configuration and conformational behavior were 1H-NMR spectroscopically clarified. The latter was brought in relation to their relative binding affinity (RBA) to the estrogen receptor as well as to their estrogenic potency. In contrast to the RR/SS-configurated diamines, the R/S-configurated ones showed marked estrogenic properties which correlate with the RBA's. In the related R/S-configurated complexes the estrogenic activity is determined by the same structural requirements as in the diamine series. However, a correlation between RBA's and estrogenic potencies is missing. The connection between spatial structure and activity is discussed by use of a drug-receptor model recently proposed by Höltje and Dall.

Animals↗

Does [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]- dichloroplatinum(II) act on the hormone-sensitive, murine breast cancer as a biological response modifier? Part 1: The MXT-M-3.2 breast cancer stimulates the growth of an identical second graft; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplat inum (II) inhibits this process.

The MXT-M-3.2 breast cancer implanted into female B6D2F1 mice accelerates the growth of an identical second tumor. This process is inhibited by [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl) ethylenediamine]dichloroplatinum(II). The possible modes of action of this compound as a biological response modifier are discussed.

Animals↗

Metal complexes of tetrapodal ligands: synthesis, spectroscopic and thermal studies, and X-ray crystal structure studies of Na(I), Ca(II), Sr(II), and Ba(II) complexes of tetrapodal ligands N,N,N',N'-tetrakis(2-hydroxypropyl)ethylenediamine and N,N,N',N'-tetrakis(2-hydroxyethyl)ethylenediamine.

Twelve complexes 1-12 of general category [M(ligand)(anion)(x)(water)(y)], where ligand = N,N,N',N'-tetrakis(2-hydroxypropyl/ethyl)ethylenediamine (HPEN/HEEN), anion = anions of picric acid (PIC), 3,5-dinitrobenzoic acid (DNB), 2,4-dinitrophenol (DNP), and o-nitrobenzoic acid (ONB), M = Ca(2+), Sr(2+), Ba(2+), or Na(+), x = 1 and 2, and y = 0-4, were synthesized. All of these complexes were characterized by elemental analysis, IR, (1)H and (13)C NMR, and thermal studies. X-ray crystal studies of these complexes 1-12, [Ca(HPEN)(H(2)O)(2)](PIC)(2).H(2)O (1), [Ca(HEEN)(PIC)](PIC) (2), Ba(HPEN)(PIC)(2) (3), [Na(HPEN)(PIC)](2) (4), Ca(HPEN)(H(2)O)(2)](DNB)(2).H(2)O (5),Ca(HEEN)(H(2)O)](DNB)(2).H(2)O (6), [Sr(HPEN)(H(2)O)(3)](DNB)(2) (7), [Ba(HPEN)(H(2)O)(2)](DNB)(2).H(2)O](2) (8), [[Ba(HEEN)(H(2)O)(2)](ONB)(2)](2) (9), [[Sr(HPEN)(H(2)O)(2)](DNP)(2)](2) (10), [[Ba(HPEN)(H(2)O)(2)](DNP)(2)](2) (11), and [Ca(HEEN)(DNP)](DNP) (H(2)O) (12), have been carried out at room temperature. Factors which influence the stability and the type of complex formed have been recognized as H-bonding interactions, presence/absence of solvent, nature of the anion, and nature of the cation. Both the ligands coordinate the metal ion through all the six available donor atoms. The complexes 1 and 5-11 have water molecules in the coordination sphere, and their crystal structures show that water is playing a dual character. It coordinates to the metal ion on one hand and strongly hydrogen bonds to the anion on the other. These strong hydrogen bonds stabilize the anion and decrease the cation-anion interactions by many times to an extent that the anions are completely excluded out of the coordination sphere and produce totally charge-separated complexes. In the absence of water molecules as in 2 and 3 the number of hydrogen bonds is reduced considerably. In both the complexes the anions case interact more strongly with the metal ion to give rise to a partially charge-separated 2 or tightly ion-paired 3 complex. High charge density Ca(2+) forms only monomeric complexes. It has more affinity toward stronger nucleophiles such as DNP and PIC with which it gives partially charge-separated eight-coordinated complexes. But with relatively weaker nucleophile like DNB, water replaces the anion and produces a seven coordinated totally charge-separated complex. Sr(2+) with lesser charge/radius ratio forms only charge-separated monomeric as well as dimeric complexes. Higher coordination number of Sr(2+) is achieved with coordinated water molecules which may be bridging or nonbridging in nature. All charge-separated complexes of the largest Ba(2+) are dimeric with bridging water molecules. Only one monomeric ion-paired complex was obtained with Ba(PIC)(2). Na(+) forms a unique dinuclear cryptand-like complex with HPEN behaving as a heptadentate chelating-cum-bridging ligand.

Journal Article↗

A one-dimensional iodine-bridged Pt(II)/Pt(IV) mixed-valence complex, catena-poly[[[bis(ethylenediamine)platinum(II)]-mu-iodo-[bis(ethylenediamine)platinum(IV)]-mu-iodo] hydrogenphosphate dihydrogenphosphate iodide trihydrate].

The title compound, {[PtIIPtIVI2(C2H8N2)4](HPO4)(H2PO4)I.3H2O}n, has a chain structure composed of square-planar [Pt(en)2]2+ and elongated octahedral trans-[PtI2(en)2]2+ cations (en is ethylenediamine) stacked alternately along the c axis and bridged by the I atoms; a three-dimensionally valence-ordered system exists with respect to the Pt sites. The title compound also has a unique cyclic tetramer structure composed of two hydrogenphosphate and two dihydrogenphosphate ions connected by strong hydrogen bonds [O...O = 2.522 (10), 2.567 (10) and 2.569 (11) A]. The Pt and I atoms form a zigzag ...I-PtIV-I...PtII... chain, with PtIV-I bond distances of 2.6997 (7) and 2.6921 (7) A, interatomic PtII...I distances of 3.3239 (8) and 3.2902 (7) A, and PtIV-I...PtII angles of 154.52 (3) and 163.64 (3) degrees . The structural parameters indicating the mixed-valence state of platinum, expressed by delta = (PtIV-I)/(PtII-I), are 0.812 and 0.818 for the two independent I atoms.

Journal Article↗

Metabolism of some ethylenediamine derivatives with antiarrhythmic properties. I. Absorption, distribution in tissues and excretion of 14-C labelled N, N'-bis-[3-(p-methoxyphenoxy)-2-hydroxypropyl]-ethylenediamine dimethanesulphonate (MK-142) in rats.

14-C labelled MK-142 (specific activity 2.875 muCi/mg) (1.762 mCi/mM) passes very rapidly from the blood stream to the majority of tissues since 5 min after the iv administration the blood contained only about 5% of the administered dose. The relatively high content of MK-142 in the myocardium as compared with its content in the skeletal muscles indicates a high affinity of the examined substance to the heart muscle. MK-142 is excreted via kidneys, alimentary tract and respiratory ways.

Animals↗

The first oxygen-bonded sulfenate ion: crystal and molecular structures of bis(ethylenediamine)(2-pyridinesulfenato-O)cobalt(III) and bis(ethylenediamine)(2-pyridinesulfinato-O)cobalt(III).

The first O-bonded sulfenate species [Co(en)2(py-SO-O)]2+ has been synthesized by isomerization of its S-bonded linkage isomer, [Co(en)2(pyridine-2-sulfenate-S]2+. The sulfenate ion in both forms is stabilized by coordination to the electropositive cobalt(III) ion. The driving force for the formation of the O-bonded sulfenate linkage isomer comes from the four to five membered ring expansion which accompanies the rearrangement. Crystal structures of the green O-sulfenate confirm the formulation and reveal varying amounts of a cocrystallized O-bonded sulfinate diastereomer. The cations have essentially identical structures except for the extra oxygen in the O-sulfinate. Differences in packing of cations and perchlorates give rise to two different structural types for the salts, corresponding to sulfenate-rich and sulfinate-rich phases.

Journal Article↗